Dr Paul Timpson
Garvan Institute of Medical Research
Targeting pancreatic cancer vulnerabilities
In this project, Professor Timpson and his team will use cutting-edge imaging technology and lab models that mimic pancreatic cancer to enable them to watch tumour response to treatment in real-time and to map the areas of the tumour where treatment has little of no effect. By observing live pancreatic cancer in this way, the team hope to identify the factors that limit treatment effectiveness, how best to target tumour vulnerability, and when to attack these vulnerabilities for maximum effect.
Prof Timpson and his team hope their findings will lead to much needed new treatment approaches for pancreatic cancer.